Jump to the top of the page
Mortiz Rottwinkel

Moritz-Benedikt Rottwinkel

Managing Director, Healthcare Services, Head of Frankfurt Office

Frankfurt aerial view

About Moritz

Moritz-Benedikt Rottwinkel is a managing director for William Blair based in the firm’s Frankfurt office. He joined William Blair's investment banking team in 2012. Prior to William Blair, he worked for SEB Enskilda Corporate Finance and Lincoln International.

Languages Spoken

German
English

Notable Transactions

  • Not Disclosed

    has partnered with

    April 2024

    William Blair acted as the exclusive financial advisor to TT medic GmbH and its shareholders in connection with entering a partnership with Trill Impact.

    Read more
  • Not Disclosed

    has been acquired by

    October 2022

    William Blair acted as the exclusive financial advisor to CEVEC Pharmaceuticals in connection with its sale to Danaher Corporation (NYSE: DHR) and its portfolio company Cytiva.

    Read more
  • Not Disclosed

    a portfolio company of International Chemical Investors Group

    has been acquired by

    August 2022

    William Blair acted as the exclusive financial advisor to International Chemical Investors Group in connection with its pending sale of its portfolio company, CordenPharma, to Astorg.

    Read more
  • Not Disclosed

    has been acquired by

    February 2022

  • €123,000,000

    has been acquired by

    October 2021

    William Blair acted as financial advisor to Hemovent, a company backed by a consortium of institutional investors led by MIG Capital in connection with its sale to MicroPort (SEHK Ticker: 0853) for €123m in total consideration (including future milestone payments).

    Read more
  • Not Disclosed

    a portfolio company of
    Water Street Healthcare Partners

    has been acquired by

    a portfolio company of CVC Capital Partners, Téthys Invest and CDPQ

    September 2021

  • Not Disclosed

    has been acquired by

    August 2021

    William Blair acted as the exclusive financial advisor to evitria, a portfolio company of Afinum Management and SHS Capital, in connection with its sale to Atlas Antibodies, a portfolio company of Patricia Industries.

    Read more
  • Not Disclosed

    has sold its facility in Couvet, Switzerland to

    July 2021

  • €360,000,000

    Sartorius Stedim Biotech GmbH

    has acquired

    November 2020

  • Not Disclosed

    has been acquired by

    December 2019

  • Not Disclosed

    has been acquired by

    January 2020

  • Not Disclosed

    has sold its manufacturing facility in Anagni, Italy to

    December 2019

  • Rigorous pursuit of your success. Every transaction. Every time.

    Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.

    More about investment banking at William Blair
    Aerial view of highway interchange at night

    Healthcare Services

    William Blair’s Healthcare Services team is a trusted partner to providers, suppliers, and solutions providers across the healthcare continuum. Our knowledge of emerging healthcare trends and the nuances of reimbursement models have allowed us to help clients access capital and form valuable strategic partnerships.

    More about our healthcare services expertise
    Petri dishes

    About William Blair

    William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

    • 1935

      Year William Blair was founded

    • 1,900+

      Employees worldwide

    • 149 billion+

      Client assets

    • 89 Years

      Independent and employee-owned

    • 20+

      Offices worldwide

    • ~650

      Companies under coverage

    As of September 30, 2024
    *Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

    More about William Blair affiliated entities

    This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.

    Copyright © 2024 William Blair & Company, L.L.C. | Privacy Terms

    Are you sure you want to leave?

    Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

    For disclosure information, please visit www.williamblair.com/disclosures